about
Molecular machinery for non-vesicular trafficking of ceramideIdentification and characterization of a novel human type II diacylglycerol kinase, DGK kappaLipid phosphate phosphatases 1 and 3 are localized in distinct lipid raftsDiacylglycerol kinase alpha suppresses tumor necrosis factor-alpha-induced apoptosis of human melanoma cells through NF-kappaB activationAW551984: a novel regulator of cardiomyogenesis in pluripotent embryonic cellsUltra-sensitive detection of tumorigenic cellular impurities in human cell-processed therapeutic products by digital analysis of soft agar colony formationTRPC3-GEF-H1 axis mediates pressure overload-induced cardiac fibrosisTRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling.Diacylglycerol kinase delta associates with receptor for activated C kinase 1, RACK1.Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis.Stereoselective synthesis and structure-activity relationship of novel ceramide trafficking inhibitors. (1R,3R)-N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide and its analogues.Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells.CERT mediates intermembrane transfer of various molecular species of ceramides.A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture systemLysophosphatidic acid induces neointima formation through PPARgamma activation.Diacylglycerol kinases: why so many of them?Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells.Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma.Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.Stable knock-down of the sphingosine 1-phosphate receptor S1P1 influences multiple functions of human endothelial cells.Optimal lysophosphatidic acid-induced DNA synthesis and cell migration but not survival require intact autophosphorylation sites of the epidermal growth factor receptor.Identification of a Gene Encoding Slow Skeletal Muscle Troponin T as a Novel Marker for Immortalization of Retinal Pigment Epithelial Cells.Diacylglycerol kinase eta augments C-Raf activity and B-Raf/C-Raf heterodimerization.Diacylglycerol kinase gamma interacts with and activates beta2-chimaerin, a Rac-specific GAP, in response to epidermal growth factor.A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis.In vitro detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human induced pluripotent stem cells.Characterization of the cell growth analysis for detection of immortal cellular impurities in human mesenchymal stem cells.Localization, topology, and function of the LCB1 subunit of serine palmitoyltransferase in mammalian cells.Tumorigenicity assessment of human cell-processed therapeutic products.Tumorigenicity-associated characteristics of human iPS cell linesTumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical applicationSALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiationCXCL4/PF4 is a predictive biomarker of cardiac differentiation potential of human induced pluripotent stem cellsRab7 regulates maturation of melanosomal matrix protein gp100/Pmel17/SilvPhorbol ester and hydrogen peroxide synergistically induce the interaction of diacylglycerol kinase gamma with the Src homology 2 and C1 domains of beta2-chimaerinHypoxia-induced interaction of filamin with Drp1 causes mitochondrial hyperfission-associated myocardial senescence
P50
Q24302195-65397133-4FCF-46E9-8BC9-0D866A976F44Q24337754-C79F3883-A815-416C-AAF8-83F549D98A39Q28265699-773CBCEB-EA47-4DDC-95BC-D576B7234BB2Q28286802-1392EBA8-A31D-42EF-9188-06D3399CCACBQ28587426-84A32950-A06F-4AD1-BFC0-71ABBB38B66CQ28606626-FB4A5126-6E31-407E-B61E-409475E09833Q28817018-C260F022-71C3-46FE-8F7C-150FDDF524C4Q30828286-3432AA7D-C2E1-4500-B315-54DE46F8DE5FQ33439327-734316BC-9BC3-4A66-939C-77212D552EDFQ34157831-AA0F4E02-88DF-430B-9EEE-6E306863F8A9Q34220369-7D8A840C-1250-4FA0-9621-14B0E97143D2Q34278003-6F4B85F3-B920-40AD-87F9-0B11AE65B842Q34376027-6CF7121F-1D82-47B0-8F24-6D2DCB3D5DA0Q34408404-563F56C2-1A02-4CF7-A8A2-4D27F7E36182Q36402330-71F2385D-82AC-4A13-B4D6-BD992E94FB2CQ36826263-21B6D29D-29AA-4F87-B640-7DFA07E780E5Q38780345-64E9DDBC-E4F6-40BA-81B0-41565EE51F31Q40345265-65AC2EDE-5BD1-41A9-84F4-4DBD7C315851Q40395497-82881582-077A-433B-AA1F-17552C411E33Q40477230-ACF56BDC-3401-4DF5-A612-26213E3F4A8CQ40516137-99F64536-DC24-4518-B602-ED61EBCAE825Q41420025-4D941627-3AA3-45EB-93A6-B5A3E471AE10Q42683550-B23A0BB2-CEC0-47C1-A87C-8EF361F5401FQ42831632-8EEABED7-353D-4C67-8F89-982C7FBDE8A9Q43458274-117DD504-AF9E-49B7-894A-D567E0EE0ADCQ45868109-8D639F9D-11D4-4E96-8617-7FAD99BB87DAQ45871352-1E3DE46D-43FE-48A4-80D0-7821D2FEE3E7Q51841172-3D30D01C-1109-43F1-B2FF-A2886A4D0CE2Q52937145-36610CEA-2B6A-4DDE-A183-8D164FA7C3E6Q57031173-CFB9A71E-AD8F-4B1B-BA93-3804D9BDBDB6Q61796465-9FEBEFBE-31D6-435A-A245-73F9608CEDC1Q64054825-A52AF6DC-EB85-4AA3-9D19-28A60624DCADQ64091028-C57D50CC-0286-499D-AC5D-E68675A95732Q80599588-4E356991-4915-44C1-A6E8-D8E9A386DB75Q81095211-423AD2B0-108B-4361-9C43-AB84CF5B1522Q93052190-14D4449B-A3B5-4DAE-96FC-5146F15A3BAA
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1011-0815
@en
name
Satoshi Yasuda
@ast
Satoshi Yasuda
@en
Satoshi Yasuda
@es
Satoshi Yasuda
@nl
type
label
Satoshi Yasuda
@ast
Satoshi Yasuda
@en
Satoshi Yasuda
@es
Satoshi Yasuda
@nl
prefLabel
Satoshi Yasuda
@ast
Satoshi Yasuda
@en
Satoshi Yasuda
@es
Satoshi Yasuda
@nl
P106
P31
P496
0000-0002-1011-0815